Oral Excipients

galenIQ™ is a sweet-tasting water soluble filler binder derived from sugar beet. It is available in several different morphological forms...

The number of lipophilic drug candidates in pharmaceutical discovery pipelines has increased in recent years. These drugs often possess physicochemical...

There is much interest in converting poorly water-soluble drugs into nanocrystals as they provide extremely high surface area that increases dissolution rate...

The dearth of new medicines effective against antibiotic-resistant bacteria presents a growing global public health concern1. For more than five...

Lamination is a common industrial problem during the production of pharmaceutical tablets. It corresponds to a failure of the tablet...

The authors attempted to fabricate a novel lipid-based formulation of a lipophilic drug, nisoldipine (NISO). As NISO belongs to BCS...

Colorectal cancer (CRC) is the third most commonly diagnosed cancer in the world and is the second leading cause of...

The oral route of administration for lipid-based nanocarriers is of immense importance for the drugs having low bioavailability because of extensive first-pass metabolism. These...

An oral colon delivery platform based on a novel combination strategy, leveraging multiple physiological characteristics of the intestine, is proposed....

Various physiological factors in the gastrointestinal (GI) tract affect the in vivo performance of orally administered dosage forms. In this review article,...